Sofosbuvir/velpatasvir for 12 vs. 6 weeks for the treatment of recently acquired hepatitis C infection - Concepedia

Concepedia

Publication | Open Access

Sofosbuvir/velpatasvir for 12 vs. 6 weeks for the treatment of recently acquired hepatitis C infection

DOI Full Paper Access

47

Citations

25

References

2021

Year

Gail Matthews, Sanjay Bhagani, Marc van der Valk, Juergen Rockstroh, Jordan J. Feld, Andri Rauch, Christine Thurnheer, Julie Bruneau, Arthur Kim, Margaret Hellard,

Journal of Hepatology

HepatologyHepatitis CViral HepatitisAntiviral TherapyHepatitisVirologyChronic Viral InfectionInfection ControlHepatitis C InfectionAntiviral DrugMedicine

References

	Year	Citations

Page 1

Page 1